107 related articles for article (PubMed ID: 38728212)
21. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Dauer P; Zhao X; Gupta VK; Sharma N; Kesh K; Gnamlin P; Dudeja V; Vickers SM; Banerjee S; Saluja A
Cancer Res; 2018 Mar; 78(5):1321-1333. PubMed ID: 29259015
[TBL] [Abstract][Full Text] [Related]
22. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
23. [Metastasis of pancreatic tumors].
Häberle L; Braren R; Schlitter AM; Esposito I
Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
[TBL] [Abstract][Full Text] [Related]
24. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
Zhang L; Yao J; Li W; Zhang C
Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
[TBL] [Abstract][Full Text] [Related]
25. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E
Front Immunol; 2021; 12():612271. PubMed ID: 33889150
[TBL] [Abstract][Full Text] [Related]
26. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
Sperb N; Tsesmelis M; Wirth T
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cancer subtypes: a roadmap for precision medicine.
Torres C; Grippo PJ
Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
30. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
[TBL] [Abstract][Full Text] [Related]
31. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
32. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
Zhu K; Cai L; Cui C; de Los Toyos JR; Anastassiou D
PLoS Comput Biol; 2021 Jul; 17(7):e1009228. PubMed ID: 34283835
[TBL] [Abstract][Full Text] [Related]
33. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
34. Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts.
Chen X; Huang H
Cancer Cell; 2024 May; 42(5):744-746. PubMed ID: 38670089
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer stem cells: new insights and perspectives.
Dorado J; Lonardo E; Miranda-Lorenzo I; Heeschen C
J Gastroenterol; 2011 Aug; 46(8):966-73. PubMed ID: 21698355
[TBL] [Abstract][Full Text] [Related]
36. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.
Kim J; Hoffman JP; Alpaugh RK; Rhim AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS
Cell Rep; 2013 Jun; 3(6):2088-99. PubMed ID: 23791528
[TBL] [Abstract][Full Text] [Related]
37. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer.
Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L
Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335
[TBL] [Abstract][Full Text] [Related]
38. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
39. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic biomarkers: could they be the answer?
Lamarca A; Feliu J
World J Gastroenterol; 2014 Jun; 20(24):7819-29. PubMed ID: 24976720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]